中文 | English
Return
Total: 8 , 1/1
Show Home Prev Next End page: GO
Author:( Yingquan WU)

1.The primary and second prevention of acute cerebral infarction

Yingquan WU ; Wei WU ; Li ZHANG

Chinese Journal of Practical Internal Medicine 2000;0(11):-

2.Preparation and Quality Control of Internal Eye Perfuse Aqua

Pengxin LIN ; Gaoxiang LIN ; Yingquan WU

China Pharmacy 1991;0(05):-

3.Diagnosis and treatment of craniofacial pain

Yingquan WU ; Wei WU ; Yinan HOU ; Ping LIANG

Chinese Journal of Practical Internal Medicine 2001;0(06):-

4.Relationship between insulin resistance and erythrocyte insulin receptors in patients with cerebral infarction

Ming YU ; Han CHEN ; Qing ZHAO ; Yingquan WU

Chinese Journal of Tissue Engineering Research 2005;9(41):160-161

5.Association between atherosclerotic brain infarction and human leucocyte antigen-Ⅱ gene of the Han Nationality in north China: Technique of sequent and specific primer polymerase chain reaction

Shuangyan ZHANG ; Yingquan WU ; Xianzhong ZHANG ; Fenglin CHAO

Chinese Journal of Tissue Engineering Research 2005;9(33):164-166

6.Epidemiological characteristics of high-risk population for cardiovascular disease of Shanghai residents

Yuzhuo WANG ; Yang ZHENG ; Yingquan WANG ; Cui WU ; Haiyan GU ; Yiying ZHANG ; Yan XU ; Sen WANG ; Xin ZHANG ; Yu JIANG ; Jia ZHAO ; Yan SHI

Shanghai Journal of Preventive Medicine 2024;36(1):64-71

7.Mechanism of cinobufagin regulating PI3K/AKT signaling pathway to reverse cisplatin resistance in ovarian cancer A2780/DDP cells

Meiling Shu ; Yue Wu ; Yingquan Ye ; Shuangshuang Zhang ; Mei Zhang

Acta Universitatis Medicinalis Anhui 2024;59(4):671-677,741

8.Cinobufagin regulates HIF-1 α/VEGF pathway to reverse drug resistance in colorectal cancer cells HCT15 /5-FU in vitro

Qinying Zhao ; Yue Wu ; Zhongxuan Gui ; Quan Zhang ; Yingquan Ye ; Gaoxiang Wang ; Mei Zhang

Acta Universitatis Medicinalis Anhui 2023;58(6):902-907

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 8 , 1/1 Show Home Prev Next End page: GO